Recurrent Breast Cancer Withdrawn Phase 2 Trials for Antineoplaston A10 (DB11702)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003455Antineoplaston Therapy in Treating Women With Advanced Breast CancerTreatment
NCT00003536Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast CancerTreatment